• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吗啡免疫调节作用中中枢阿片受体的证据:作用机制的潜在机制综述。

Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action.

作者信息

Mellon R D, Bayer B M

机构信息

Georgetown University Medical Center, Department of Pharmacology, Washington, DC 20007, USA.

出版信息

J Neuroimmunol. 1998 Mar 15;83(1-2):19-28. doi: 10.1016/s0165-5728(97)00217-8.

DOI:10.1016/s0165-5728(97)00217-8
PMID:9610669
Abstract

This review will discuss studies demonstrating that activation of opioid receptors within the central nervous system alters various immune system parameters. Specifically, natural killer cell cytolytic activity and lymphocyte proliferative responses to mitogen appear to be modulated predominantly, if not exclusively, through central opioid receptors. The potential mechanisms by which central opioid receptors appear to modulate these peripheral immune functions will be examined by evaluating the role of both the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system. The studies discussed below indicate that acute administration of morphine or related compounds appears to primarily alter peripheral immune function through the sympathetic nervous system, while more prolonged exposure to opioids alter the immune system predominantly by activation of the HPA axis. Finally, the potential clinical relevance of these observations are discussed in relationship to both the therapeutic use, as well as the abuse of opioid compounds.

摘要

本综述将讨论一些研究,这些研究表明中枢神经系统内阿片受体的激活会改变各种免疫系统参数。具体而言,自然杀伤细胞的细胞溶解活性以及淋巴细胞对有丝分裂原的增殖反应似乎主要(如果不是唯一的话)通过中枢阿片受体受到调节。通过评估下丘脑 - 垂体 - 肾上腺(HPA)轴和自主神经系统的作用,将研究中枢阿片受体调节这些外周免疫功能的潜在机制。下面讨论的研究表明,急性给予吗啡或相关化合物似乎主要通过交感神经系统改变外周免疫功能,而长时间接触阿片类药物则主要通过激活HPA轴来改变免疫系统。最后,将结合阿片类化合物的治疗用途以及滥用情况来讨论这些观察结果的潜在临床相关性。

相似文献

1
Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action.吗啡免疫调节作用中中枢阿片受体的证据:作用机制的潜在机制综述。
J Neuroimmunol. 1998 Mar 15;83(1-2):19-28. doi: 10.1016/s0165-5728(97)00217-8.
2
Opioid mediated effects on the immune system: sympathetic nervous system involvement.
J Neuroimmunol. 1998 Mar 15;83(1-2):29-35. doi: 10.1016/s0165-5728(97)00218-x.
3
Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.中枢阿片受体亚型在吗啡诱导的外周淋巴细胞活性改变中的作用。
Brain Res. 1998 Apr 6;789(1):56-67. doi: 10.1016/s0006-8993(97)01529-1.
4
The opioid-cytokine connection.阿片类药物与细胞因子的联系。
J Neuroimmunol. 1998 Mar 15;83(1-2):63-9. doi: 10.1016/s0165-5728(97)00222-1.
5
Opioids and immune modulation: more questions than answers.阿片类药物与免疫调节:问题多于答案。
Br J Anaesth. 2013 Jul;111(1):80-8. doi: 10.1093/bja/aet153.
6
The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.吗啡、尼古丁和埃博霉素对淋巴细胞活性及下丘脑-垂体-肾上腺轴反应的影响。
J Pharmacol Exp Ther. 1999 Feb;288(2):635-42.
7
Opioids, opioid receptors, and the immune response.阿片类药物、阿片受体与免疫反应。
Drug Alcohol Depend. 2001 Apr 1;62(2):111-23. doi: 10.1016/s0376-8716(00)00181-2.
8
Opioid therapy and immunosuppression: a review.阿片类药物治疗与免疫抑制:综述
Am J Ther. 2004 Sep-Oct;11(5):354-65. doi: 10.1097/01.mjt.0000132250.95650.85.
9
Evidence for opioid receptors on cells involved in host defense and the immune system.参与宿主防御和免疫系统的细胞上存在阿片受体的证据。
J Neuroimmunol. 1998 Mar 15;83(1-2):45-56.
10
Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.神经肽Y Y1受体介导吗啡引起的自然杀伤细胞活性降低。
J Neuroimmunol. 2006 Aug;177(1-2):18-26. doi: 10.1016/j.jneuroim.2006.05.002.

引用本文的文献

1
Anesthesia and cancer recurrence: an overview.麻醉与癌症复发:综述
J Anesth Analg Crit Care. 2022 Jul 20;2(1):33. doi: 10.1186/s44158-022-00060-9.
2
Chronic Pain Management During a Pandemic: Evidence-Based Review.大流行期间的慢性疼痛管理:循证综述
Turk J Anaesthesiol Reanim. 2022 Jun;50(3):159-166. doi: 10.5152/TJAR.2022.1328.
3
Opioids in the Elderly Patients with Cognitive Impairment: A Narrative Review.老年认知障碍患者中的阿片类药物:一篇叙述性综述。
Pain Ther. 2022 Jun;11(2):381-394. doi: 10.1007/s40122-022-00376-y. Epub 2022 Apr 5.
4
A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19.综述:新型冠状病毒肺炎患者肌肉骨骼疼痛的表现、机制及治疗
Front Pain Res (Lausanne). 2022 Mar 10;3:826160. doi: 10.3389/fpain.2022.826160. eCollection 2022.
5
Practical Advices for Treating Chronic Pain in the Time of COVID-19: A Narrative Review Focusing on Interventional Techniques.2019冠状病毒病时期慢性疼痛治疗的实用建议:聚焦介入技术的叙述性综述
J Clin Med. 2021 May 25;10(11):2303. doi: 10.3390/jcm10112303.
6
Approaches and Best Practices for Managing Cancer Pain within the Constraints of the COVID-19 Pandemic in India.印度在2019冠状病毒病大流行限制下管理癌症疼痛的方法和最佳实践
Indian J Palliat Care. 2020 Jun;26(Suppl 1):S106-S115. doi: 10.4103/IJPC.IJPC_216_20. Epub 2020 Jun 30.
7
Management of Immunity Alteration-Induced Chronic Pain During the Coronavirus Disease-2019 (COVID-19) Pandemic.2019年冠状病毒病(COVID-19)大流行期间免疫改变所致慢性疼痛的管理
Front Microbiol. 2020 Sep 24;11:572318. doi: 10.3389/fmicb.2020.572318. eCollection 2020.
8
Cancer pain treatment during the COVID-19 pandemic: institutional recommendations.2019冠状病毒病大流行期间的癌症疼痛治疗:机构建议
Clinics (Sao Paulo). 2020;75:e2208. doi: 10.6061/clinics/2020/e2208.
9
Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel.在 COVID-19 大流行期间关爱疼痛患者:国际专家小组的共识建议。
Anaesthesia. 2020 Jul;75(7):935-944. doi: 10.1111/anae.15076. Epub 2020 Apr 26.
10
Potential of Glial Cell Modulators in the Management of Substance Use Disorders.神经胶质细胞调制物在物质使用障碍治疗中的潜力。
CNS Drugs. 2020 Jul;34(7):697-722. doi: 10.1007/s40263-020-00721-9.